hormonalMolecular Weight: 3367.2

CJC-1295 (No DAC)

Mod GRF 1-29

A modified version of GHRH 1-29, designed to stimulate growth hormone release.

Shop CJC-1295 (No DAC)

Mechanism

GHRH analog that stimulates the pituitary gland to release growth hormone. Modified for increased stability.

Half-Life

30 minutes

Administration

Subcutaneous

Technical Protocol

CJC-1295 (No DAC): Comprehensive Research Guide

Overview

CJC-1295 (No DAC) is a modified version of Growth Hormone Releasing Hormone (GHRH) 1-29, designed to stimulate natural growth hormone pulses from the pituitary gland.

Mechanism of Action

Stimulates pituitary GH release
Works synergistically with GHRPs like Ipamorelin
Short half-life allows for natural pulsatile release

This information is for research and educational purposes only.

Peer-Reviewed Citations

Prolonged stimulation of growth hormone secretion by CJC-1295

Teichman SL, et al. • J Clin Endocrinol Metab (2006)

Access Research

Frequently Asked Questions

What is CJC-1295 (No DAC)?

A modified version of GHRH 1-29, designed to stimulate growth hormone release.

How does CJC-1295 (No DAC) work?

GHRH analog that stimulates the pituitary gland to release growth hormone. Modified for increased stability.

What is the typical dosage of CJC-1295 (No DAC) in research?

The typical research dosage of CJC-1295 (No DAC) is 100 mcg (range: 100 mcg). Common administration routes include Subcutaneous.

How should CJC-1295 (No DAC) be stored?

Store at 2-8°C, protect from light

Source CJC-1295 (No DAC) for Your Research

Third-party tested, EU-shipped, certificate of analysis included. High-purity CJC-1295 (No DAC) available from our verified research partner.